IBDEI1X0 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,30581,1,2,0)
;;=2^Outpt Prolonged Svc,Ea Addl 30 Min
;;^UTILITY(U,$J,358.3,30581,1,3,0)
;;=3^99355
;;^UTILITY(U,$J,358.3,30582,0)
;;=99356^^122^1570^1^^^^1
;;^UTILITY(U,$J,358.3,30582,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30582,1,2,0)
;;=2^Inpt Prolonged Svc,1st Hr
;;^UTILITY(U,$J,358.3,30582,1,3,0)
;;=3^99356
;;^UTILITY(U,$J,358.3,30583,0)
;;=99357^^122^1570^2^^^^1
;;^UTILITY(U,$J,358.3,30583,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30583,1,2,0)
;;=2^Inpt Prolonged Svc,Ea Addl 30 Min
;;^UTILITY(U,$J,358.3,30583,1,3,0)
;;=3^99357
;;^UTILITY(U,$J,358.3,30584,0)
;;=99358^^122^1570^5^^^^1
;;^UTILITY(U,$J,358.3,30584,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30584,1,2,0)
;;=2^Prolonged Svc w/o Patient,1st hr
;;^UTILITY(U,$J,358.3,30584,1,3,0)
;;=3^99358
;;^UTILITY(U,$J,358.3,30585,0)
;;=99359^^122^1570^6^^^^1
;;^UTILITY(U,$J,358.3,30585,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30585,1,2,0)
;;=2^Prolonged Svc w/o Patient,Ea Addl 30min
;;^UTILITY(U,$J,358.3,30585,1,3,0)
;;=3^99359
;;^UTILITY(U,$J,358.3,30586,0)
;;=36430^^122^1571^1^^^^1
;;^UTILITY(U,$J,358.3,30586,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30586,1,2,0)
;;=2^Blood Transfusion Service
;;^UTILITY(U,$J,358.3,30586,1,3,0)
;;=3^36430
;;^UTILITY(U,$J,358.3,30587,0)
;;=36415^^122^1571^2^^^^1
;;^UTILITY(U,$J,358.3,30587,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30587,1,2,0)
;;=2^Routine Venipuncture
;;^UTILITY(U,$J,358.3,30587,1,3,0)
;;=3^36415
;;^UTILITY(U,$J,358.3,30588,0)
;;=93784^^122^1572^2^^^^1
;;^UTILITY(U,$J,358.3,30588,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30588,1,2,0)
;;=2^Amb BP Monitor 24+ hrs,Intrp & Rpt
;;^UTILITY(U,$J,358.3,30588,1,3,0)
;;=3^93784
;;^UTILITY(U,$J,358.3,30589,0)
;;=93786^^122^1572^3^^^^1
;;^UTILITY(U,$J,358.3,30589,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30589,1,2,0)
;;=2^Amb BP Monitor 24+ hrs,Rpt Only
;;^UTILITY(U,$J,358.3,30589,1,3,0)
;;=3^93786
;;^UTILITY(U,$J,358.3,30590,0)
;;=93788^^122^1572^1^^^^1
;;^UTILITY(U,$J,358.3,30590,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30590,1,2,0)
;;=2^Amb BP Analysis & Rpt
;;^UTILITY(U,$J,358.3,30590,1,3,0)
;;=3^93788
;;^UTILITY(U,$J,358.3,30591,0)
;;=93790^^122^1572^4^^^^1
;;^UTILITY(U,$J,358.3,30591,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30591,1,2,0)
;;=2^Amb BP Review,Intrp & Rpt
;;^UTILITY(U,$J,358.3,30591,1,3,0)
;;=3^93790
;;^UTILITY(U,$J,358.3,30592,0)
;;=93770^^122^1572^5^^^^1
;;^UTILITY(U,$J,358.3,30592,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30592,1,2,0)
;;=2^Measure Venous Pressure
;;^UTILITY(U,$J,358.3,30592,1,3,0)
;;=3^93770
;;^UTILITY(U,$J,358.3,30593,0)
;;=J0636^^122^1573^1^^^^1
;;^UTILITY(U,$J,358.3,30593,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30593,1,2,0)
;;=2^Calcitriol per 0.1 MCG
;;^UTILITY(U,$J,358.3,30593,1,3,0)
;;=3^J0636
;;^UTILITY(U,$J,358.3,30594,0)
;;=J0713^^122^1573^2^^^^1
;;^UTILITY(U,$J,358.3,30594,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30594,1,2,0)
;;=2^Ceftazidime per 500 MG
;;^UTILITY(U,$J,358.3,30594,1,3,0)
;;=3^J0713
;;^UTILITY(U,$J,358.3,30595,0)
;;=J1160^^122^1573^5^^^^1
;;^UTILITY(U,$J,358.3,30595,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30595,1,2,0)
;;=2^Digoxin up to 0.5 MG
;;^UTILITY(U,$J,358.3,30595,1,3,0)
;;=3^J1160
;;^UTILITY(U,$J,358.3,30596,0)
;;=Q0138^^122^1573^9^^^^1
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1X0 3758 printed Apr 09, 2024@20:58:37 Page 2
IBDEI1X0 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,30581,1,2,0)
+2 ;;=2^Outpt Prolonged Svc,Ea Addl 30 Min
+3 ;;^UTILITY(U,$J,358.3,30581,1,3,0)
+4 ;;=3^99355
+5 ;;^UTILITY(U,$J,358.3,30582,0)
+6 ;;=99356^^122^1570^1^^^^1
+7 ;;^UTILITY(U,$J,358.3,30582,1,0)
+8 ;;=^358.31IA^3^2
+9 ;;^UTILITY(U,$J,358.3,30582,1,2,0)
+10 ;;=2^Inpt Prolonged Svc,1st Hr
+11 ;;^UTILITY(U,$J,358.3,30582,1,3,0)
+12 ;;=3^99356
+13 ;;^UTILITY(U,$J,358.3,30583,0)
+14 ;;=99357^^122^1570^2^^^^1
+15 ;;^UTILITY(U,$J,358.3,30583,1,0)
+16 ;;=^358.31IA^3^2
+17 ;;^UTILITY(U,$J,358.3,30583,1,2,0)
+18 ;;=2^Inpt Prolonged Svc,Ea Addl 30 Min
+19 ;;^UTILITY(U,$J,358.3,30583,1,3,0)
+20 ;;=3^99357
+21 ;;^UTILITY(U,$J,358.3,30584,0)
+22 ;;=99358^^122^1570^5^^^^1
+23 ;;^UTILITY(U,$J,358.3,30584,1,0)
+24 ;;=^358.31IA^3^2
+25 ;;^UTILITY(U,$J,358.3,30584,1,2,0)
+26 ;;=2^Prolonged Svc w/o Patient,1st hr
+27 ;;^UTILITY(U,$J,358.3,30584,1,3,0)
+28 ;;=3^99358
+29 ;;^UTILITY(U,$J,358.3,30585,0)
+30 ;;=99359^^122^1570^6^^^^1
+31 ;;^UTILITY(U,$J,358.3,30585,1,0)
+32 ;;=^358.31IA^3^2
+33 ;;^UTILITY(U,$J,358.3,30585,1,2,0)
+34 ;;=2^Prolonged Svc w/o Patient,Ea Addl 30min
+35 ;;^UTILITY(U,$J,358.3,30585,1,3,0)
+36 ;;=3^99359
+37 ;;^UTILITY(U,$J,358.3,30586,0)
+38 ;;=36430^^122^1571^1^^^^1
+39 ;;^UTILITY(U,$J,358.3,30586,1,0)
+40 ;;=^358.31IA^3^2
+41 ;;^UTILITY(U,$J,358.3,30586,1,2,0)
+42 ;;=2^Blood Transfusion Service
+43 ;;^UTILITY(U,$J,358.3,30586,1,3,0)
+44 ;;=3^36430
+45 ;;^UTILITY(U,$J,358.3,30587,0)
+46 ;;=36415^^122^1571^2^^^^1
+47 ;;^UTILITY(U,$J,358.3,30587,1,0)
+48 ;;=^358.31IA^3^2
+49 ;;^UTILITY(U,$J,358.3,30587,1,2,0)
+50 ;;=2^Routine Venipuncture
+51 ;;^UTILITY(U,$J,358.3,30587,1,3,0)
+52 ;;=3^36415
+53 ;;^UTILITY(U,$J,358.3,30588,0)
+54 ;;=93784^^122^1572^2^^^^1
+55 ;;^UTILITY(U,$J,358.3,30588,1,0)
+56 ;;=^358.31IA^3^2
+57 ;;^UTILITY(U,$J,358.3,30588,1,2,0)
+58 ;;=2^Amb BP Monitor 24+ hrs,Intrp & Rpt
+59 ;;^UTILITY(U,$J,358.3,30588,1,3,0)
+60 ;;=3^93784
+61 ;;^UTILITY(U,$J,358.3,30589,0)
+62 ;;=93786^^122^1572^3^^^^1
+63 ;;^UTILITY(U,$J,358.3,30589,1,0)
+64 ;;=^358.31IA^3^2
+65 ;;^UTILITY(U,$J,358.3,30589,1,2,0)
+66 ;;=2^Amb BP Monitor 24+ hrs,Rpt Only
+67 ;;^UTILITY(U,$J,358.3,30589,1,3,0)
+68 ;;=3^93786
+69 ;;^UTILITY(U,$J,358.3,30590,0)
+70 ;;=93788^^122^1572^1^^^^1
+71 ;;^UTILITY(U,$J,358.3,30590,1,0)
+72 ;;=^358.31IA^3^2
+73 ;;^UTILITY(U,$J,358.3,30590,1,2,0)
+74 ;;=2^Amb BP Analysis & Rpt
+75 ;;^UTILITY(U,$J,358.3,30590,1,3,0)
+76 ;;=3^93788
+77 ;;^UTILITY(U,$J,358.3,30591,0)
+78 ;;=93790^^122^1572^4^^^^1
+79 ;;^UTILITY(U,$J,358.3,30591,1,0)
+80 ;;=^358.31IA^3^2
+81 ;;^UTILITY(U,$J,358.3,30591,1,2,0)
+82 ;;=2^Amb BP Review,Intrp & Rpt
+83 ;;^UTILITY(U,$J,358.3,30591,1,3,0)
+84 ;;=3^93790
+85 ;;^UTILITY(U,$J,358.3,30592,0)
+86 ;;=93770^^122^1572^5^^^^1
+87 ;;^UTILITY(U,$J,358.3,30592,1,0)
+88 ;;=^358.31IA^3^2
+89 ;;^UTILITY(U,$J,358.3,30592,1,2,0)
+90 ;;=2^Measure Venous Pressure
+91 ;;^UTILITY(U,$J,358.3,30592,1,3,0)
+92 ;;=3^93770
+93 ;;^UTILITY(U,$J,358.3,30593,0)
+94 ;;=J0636^^122^1573^1^^^^1
+95 ;;^UTILITY(U,$J,358.3,30593,1,0)
+96 ;;=^358.31IA^3^2
+97 ;;^UTILITY(U,$J,358.3,30593,1,2,0)
+98 ;;=2^Calcitriol per 0.1 MCG
+99 ;;^UTILITY(U,$J,358.3,30593,1,3,0)
+100 ;;=3^J0636
+101 ;;^UTILITY(U,$J,358.3,30594,0)
+102 ;;=J0713^^122^1573^2^^^^1
+103 ;;^UTILITY(U,$J,358.3,30594,1,0)
+104 ;;=^358.31IA^3^2
+105 ;;^UTILITY(U,$J,358.3,30594,1,2,0)
+106 ;;=2^Ceftazidime per 500 MG
+107 ;;^UTILITY(U,$J,358.3,30594,1,3,0)
+108 ;;=3^J0713
+109 ;;^UTILITY(U,$J,358.3,30595,0)
+110 ;;=J1160^^122^1573^5^^^^1
+111 ;;^UTILITY(U,$J,358.3,30595,1,0)
+112 ;;=^358.31IA^3^2
+113 ;;^UTILITY(U,$J,358.3,30595,1,2,0)
+114 ;;=2^Digoxin up to 0.5 MG
+115 ;;^UTILITY(U,$J,358.3,30595,1,3,0)
+116 ;;=3^J1160
+117 ;;^UTILITY(U,$J,358.3,30596,0)
+118 ;;=Q0138^^122^1573^9^^^^1
